Emerging Trends in Responsible AI and Synthetic DNA in the USA
In this article, we talk about the intersection of AI and synthetic DNA from the responsible-AI perspective. More specifically, we provide a summary of the framework of actions that is taking place in the USA along with an Executive Order from the White House, to prevent biotechnological risks associated with the misuse of AI tools.
SILVA Enters into the Global Biodata Coallition
The Global Biodata Coalition recently announced the inclusion of SILVA into its prestigious Global Core Biodata Resources (GCBRs) list, which now includes 52 top-tier data resources in life sciences and biomedical research globally.
AI Risk classification in Europe
Everyone attentive as the EU has just established the world's first rules for AI. The Commission addresses the risks of AI and classifies them into four categories: unacceptable, high, limited and minimal risk.
Ureterostomy, utis and metagenomics
How can metagenomics improve Urinary Tract Infections (UTIs) for ureterostomized patients? A paper by Huang et. al., 2023.
Lactobacillus isalae
Lactobacillus isalae sp. nov. recently published under the ISALA intitiative (University of Antwerp). Adding +1 species to the Human Vaginal Microbiota catalogue.
